Common Contracts
3 similar Securities Purchase Agreement contracts by 2seventy Bio, Inc., Bluebird Bio, Inc.
CERTAIN INFORMATION IN THIS DOCUMENT, MARKED BY [**], HAS BEEN EXCLUDED PURSUANT TO REGULATION S-K, ITEM 601(b)(10)(iv). SUCH EXCLUDED INFORMATION IS NOT MATERIAL AND IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL. ASSUMPTION AGREEMENTSecurities Purchase Agreement • November 4th, 2021 • 2seventy Bio, Inc. • Pharmaceutical preparations • New York
This ASSUMPTION AGREEMENT (this “Assumption Agreement”) is entered into as of November 3, 2021, by and between bluebird bio, Inc., a Delaware corporation (“bluebird”), and 2seventy bio, Inc., a Delaware corporation (“2seventy”).
CERTAIN INFORMATION IN THIS DOCUMENT, MARKED BY [**], HAS BEEN EXCLUDED PURSUANT TO REGULATION S-K, ITEM 601(b)(10)(iv). SUCH EXCLUDED INFORMATION IS NOT MATERIAL AND IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL. ASSUMPTION AGREEMENTSecurities Purchase Agreement • October 8th, 2021 • 2seventy Bio, Inc. • Pharmaceutical preparations • New York
This ASSUMPTION AGREEMENT (this “Assumption Agreement”) is entered into as of [l], 2021, by and between bluebird bio, Inc., a Delaware corporation (“bluebird”), and 2seventy bio, Inc., a Delaware corporation (“2seventy”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • September 8th, 2021 • Bluebird Bio, Inc. • Biological products, (no disgnostic substances) • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of September 7, 2021, by and among bluebird bio, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
